KEAP1 and diabetes mellitus: The Nrf2/Keap1/ARE signaling pathway is the primary transcriptional regulator of intracellular redox, and, in a mouse model of diabetes, induction of Nrf2 overexpression either by genetic Keap1 knockdown or by pharmacological means can enhance sensitivity to insulin and improve disease symptoms [30].